Trump Administration Threatens High Tariffs on Generic Drugs
Key Facts
- 01 — Who
Donald Trump, Apotex Inc., Canadian Generic Pharmaceutical Association
- 02 — Where
United States, Canada
- 03 — When
July 21, 2026
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR pipeline collects and structures publicly available reporting. The editorial team maintains the publication criteria and update policy.
Read our editorial policy- Revision v17/22/2026, 7:41:11 PM
President Trump announced plans to impose 100% tariffs on generic drugs starting August 1, 2028, rising to 200% the following year. The policy aims to force the reshoring of pharmaceutical production to the United States. The move is expected to significantly impact Canada, which exports a large volume of generic drugs to the U.S.